CFO of Atricure Inc (30-Year Financial, Insider Trades) M. Andrew Wade (insider trades) sold 45,000 shares of ATRC on 02/21/2020 at an average price of $39.45 a share. The total sale was $1.8 million.
AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices. AtriCure Inc has a market cap of $1.56 billion; its shares were traded at around $39.41 with and P/S ratio of 6.42. AtriCure Inc had annual average EBITDA growth of 5.40% over the past five years. GuruFocus has detected 2 severe warning signs with AtriCure Inc. .
CEO Recent Trades:
- President, CEO, & Director Michael H Carrel sold 25,000 shares of ATRC stock on 02/14/2020 at the average price of $44. The price of the stock has decreased by 10.43% since.
- President, CEO, & Director Michael H Carrel sold 25,000 shares of ATRC stock on 02/13/2020 at the average price of $43. The price of the stock has decreased by 8.35% since.
- President, CEO, & Director Michael H Carrel sold 50,000 shares of ATRC stock on 02/11/2020 at the average price of $41.5. The price of the stock has decreased by 5.04% since.
- President, CEO, & Director Michael H Carrel sold 25,000 shares of ATRC stock on 01/29/2020 at the average price of $40. The price of the stock has decreased by 1.48% since.
CFO Recent Trades:
- CFO M. Andrew Wade sold 45,000 shares of ATRC stock on 02/21/2020 at the average price of $39.45. The price of the stock has decreased by 0.1% since.
For the complete insider trading history of ATRC, click here
.
